Charles J. Dockendorff

October 17, 2026

Keysight Technologies expands 1.6T copper interconnect validation. Keysight Technologies has expanded its active and passive 1.6T copper interconnect validation for scale-out data centers. This advancement supports the growing demand for high-speed connectivity in modern data centers. Recent market analysis also highlights the company's growth potential relative to its current valuation, drawing attention to its long-term prospects in the sector.

October 10, 2026

Haemonetics Gets Price Target Hikes Amid Recent Stock Jump. Barrington Research and Mizuho both raised their price targets for Haemonetics to $140, maintaining Outperform ratings. This follows a recent 17.5% jump in the stock, which is now trading near its 52-week high. While some analysts note the current price may not be an ideal entry point, the firm's outlook has improved due to CSL Plasma developments.

October 17, 2026

Boston Scientific (BSX) Faces Catheter Recall Amid Valuation Debate. Boston Scientific announced a recall of 262,686 catheters because of a life‑threatening tip failure risk. The recall adds pressure as analysts note the company needs clear evidence of its turnaround to justify a better valuation. Truist Securities kept its rating but cut its price target to $51, reflecting a more cautious view. The stock has still moved higher than the broader market, indicating mixed investor reactions.